跳至主要内容

Evaluation of the Effect of Aspirin on Platelet Aggregation: Methodological Recommendations for Aspirin-Drug Interaction Studies

Read  full  paper  at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=53335#.VL3H3SzQrzE

ABSTRACT
Given the broad application of aspirin as antiplatelet drug, availability of standardized methodology to assess potential interaction with any co-medication on platelet aggregation is desired. We characterized the effect of aspirin (ASA) therapy on collagen-induced platelet aggregation in whole blood to define such methodology. Collagen-induced platelet whole blood aggregation was assessed in 6 healthy male volunteers on 2 occasions (Day 1, Day 7) using the Chronolog aggregometer. From Day 2 up to Day 7, subjects received a daily oral dose of 75 mg ASA. The relationship between collagen dose and platelet aggregation response was assessed. On Day 1, maximal aggregation was observed at 1 μg/mL collagen (15.3 ± 4.6 Ω) and higher. Reproducible results were obtained without any indication of intra-subject fluctuations. ASA treatment decreased maximal aggregation by 80% and 38% at 0.5 and 2.0 μg/mL collagen, respectively. Power calculations were performed based on the observed intra-subject variability and demonstrated minimal sample sizes of 9 - 11 subjects for future cross-over ASA-drug interaction studies exploring effects on platelet aggregation, which demonstrates that the proposed collagen-induced ex vivo whole blood platelet aggregation is a feasible methodology to evaluate ASA-drug interactions in healthy volunteers.
 
Cite this paper
Kruithof, A. , Moerland, M. , Anastasopoulou, E. , de Kam, P. , de Kam, M. and Burggraaf, J. (2015) Evaluation of the Effect of Aspirin on Platelet Aggregation: Methodological Recommendations for Aspirin-Drug Interaction Studies. Journal of Biomedical Science and Engineering, 8, 40-45. doi: 10.4236/jbise.2015.81004.
 
References
[1]De Meyer, S.F., Vanhoorelbeke, K., Broos, K., Salles, I.I. and Deckmyn, H. (2008) Antiplatelet Drugs. British Journal of Haematology, 142, 515-528.
http://dx.doi.org/10.1111/j.1365-2141.2008.07233.x
 
[2]Guyatt, G.H., Akl, E.A., Crowther, M., Gutterman, D.D. and Schünemann, H.J., The American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel (2012) Executive Summary: Antithrombotic The- rapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141, 7S-47S.
 
[3]Feher, G., Koltai, K., Papp, E., Alkonyi, B., Solyom, A., Kenyeres, P., et al. (2006) Aspirin Resistance—Possible Roles of Cardiovascular Risk Factors, Previous Disease History, Concomitant Medications and Haemorrheological Variables. Drugs Aging, 23, 559-567.
http://dx.doi.org/10.2165/00002512-200623070-00002
 
[4]Cardinal, D.C. and Flower, R.J. (1980) The Electronic Aggregometer: A Novel Device for Assessing Platelet Behavior in Blood. Journal of Pharmacological Methods, 3, 135-158.
http://dx.doi.org/10.1016/0160-5402(80)90024-8
 
[5]Dyszkiewicz-Korpanty, A.M., Frenkel, E.P. and Sarode, R. (2005) Approach to the Assessment of Platelet Function: Comparison between Optical-Based Platelet-Rich Plasma and Impedance-Based Whole Blood Platelet Aggregation Methods. Clinical and Applied Thrombosis/Hemostasis, 11, 25-35.
http://dx.doi.org/10.1177/107602960501100103
 
[6]Moerland, M., Kemme, M.J., van der Linden, M. and Burggraaf, J. (2010) Measurement of Collagen- and Serotonin-Induced Platelet Aggregation in Whole Blood. Expert Review of Clinical Pharmacology, 3, 177-182.
http://dx.doi.org/10.1586/ecp.10.2
 
[7]de la Cruz, J.P., Camara, S., Bellido, I., Carrasco, T. and Sanchez de la Cuesta, F. (1987) Platelet Aggregation in Human Whole Blood after Chronic Administration of Aspirin. Thrombosis Research, 46, 133-140.
http://dx.doi.org/10.1016/0049-3848(87)90213-1
 
[8]Ivandic, B.T., Giannitsis, E., Schlick, P., Staritz, P., Katus, H.A. and Hohlfeld, T. (2007) Determination of Aspirin Responsiveness by Use of Whole Blood Platelet Aggregometry. Clinical Chemistry, 53, 614-619.
http://dx.doi.org/10.1373/clinchem.2006.081059
 
[9]McGlasson, D.L. and Fritsma, G.A. (2008) Comparison of Four Laboratory Methods to Assess Aspirin Sensitivity. Blood Coagulation & Fibrinolysis, 19, 120-123.
http://dx.doi.org/10.1097/MBC.0b013e3282f40dc2
 
[10]Meves, S.H., Neubauer, H., Overbeck, U. and Endres, H.G. (2011) Is There an Ideal Way to Initiate Antiplatelet Therapy with Aspirin? A Crossover Study on Healthy Volunteers Evaluating Different Dosing Schemes with Whole Blood Aggregometry. BMC Research Notes, 4, 1-8.
 
[11]Neubauer, H., Kaiser, A.F.C., Endres, H.G., Kruger, J.C., Engelhardt, A., Lask, S., et al. (2011) Tailored Antiplatelet Therapy Can Overcome Clopidogrel and Aspirin Resistance—The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to Improve Antiplatelet Therapy. BMC Medicine, 9, 1-12.
 
[12]Spectre, G., Arnetz, L., Ostenson, C.G., Brismar, K., Li, N. and Hjemdahl, P. (2011) Twice Daily Dosing of Aspirin Improves Platelet Inhibition in Whole Blood in Patients with Type 2 Diabetes Mellitus and Micro- or Macrovascular Complications. Thrombosis and Haemostasis, 106, 491-499.
http://dx.doi.org/10.1160/TH11-04-0216
 
[13]Nieswandt, B. and Watson, S.P. (2003) Platelet-Collagen Interaction: Is GPVI the Central Receptor? Blood, 102, 449- 461.
http://dx.doi.org/10.1182/blood-2002-12-3882
 
[14]Campbell, C.L., Smyth, S., Montalescot, G. and Steinhubl, S.R. (2007) Aspirin Dose for the Prevention of Cardiovascular Disease—A Systematic Review. JAMA, 297, 2018-2024.
http://dx.doi.org/10.1001/jama.297.18.2018
 
[15]McGlasson, D. and Fritsma, G. (2009) Whole Blood Platelet Aggregometry and Platelet Function Testing. Seminars in Thrombosis and Hemostasis, 35, 168-180.
http://dx.doi.org/10.1055/s-0029-1220325
 
[16]Breddin, H.K. (2005) Can Platelet Aggregometry Be Standardized? Platelets, 16, 151-158.
http://dx.doi.org/10.1080/09537100400020161
 
[17]Kawasaki, T., Ozeki, Y., Igawa, T. and Kambayashi, J. (2000) Increased Platelet Sensitivity to Collagen in Individuals Resistant to Low-Dose Aspirin. Stroke, 31, 591-595.
http://dx.doi.org/10.1161/01.STR.31.3.591
 
[18]Kariyazono, H., Nakamura, K., Arima, J., Ayukawa, O., Onimaru, S., Masuda, H., et al. (2004) Evaluation of Anti-Platelet Aggregatory Effects of Aspirin, Cilostazol and Ramatroban on Platelet-Rich Plasma and Whole Blood. Blood Coagulation & Fibrinolysis, 15, 157-167.
http://dx.doi.org/10.1097/00001721-200403000-00007
 
[19]de Kam, P.J., El Galta, R., Kruithof, A.C., Fennema, H., van Lierop, M.J., Mihara, K., et al. (2013) No Clinically Relevant Interaction between Sugammadex and Aspirin on Platelet Aggregation and Coagulation Parameters. International Journal of Clinical Pharmacology and Therapeutics, 51, 976-985.
http://dx.doi.org/10.5414/CP201970                                                                              eww150120lx
标签：

评论

发表评论

此博客中的热门博文

Does Immigration Promote the Investment of the Monopolistic Firm?

In the present paper, we examine the effect of increasing uncertainty of immigrants’ growth on the optimal timing of investment of a firm that has a monopolistic power over the labor market. It is revealed that when the uncertainty of immigrants’ growth is more than a threshold level, increasing uncertainty of immigrants’ growth accelerates the optimal timing of firms’ investment and enhances the economic growth, even if the uncertainty of immigrants’ growth is formulated by the geometric Brownian motion, which is in sharp contrast to the standard result that an increase in the uncertainty postpones the optimal timing. With an increase in the immigrants over the past ten years, workforces in the host countries have been growing significantly to the extent that the immigrants represent 70% of the increase in the workforce in Europe, and 47% in the United States as OECD indicates. In the present paper, we attempted to investigate the effect of increased uncertainty caused by the growi...
发表评论
阅读全文

Education Policy Implementation: A Mechanism for Enhancing Primary Education Development in Zanzibar

Education is one of the fundamental rights of individuals; therefore, the government of a country needs to develop and strengthen educational policy and quality as well as to ensure that everyone has equal access to basic education. The improvement of access and quality of education in the world is becoming as an essential factor in development, whereas the basic education (primary school), is acknowledged as a foundation of the higher educational development for every country. To fulfill this goal, governments introduce several policies and procedures; however, it requires some reforms and participation from the politician, policymakers, and other stakeholders to re-examine educational policy so that it can lead to multiplication and betterment of the reforms. Educational reforms actually focus on accountability. A positive educational development and reform is very challenging and needs more effort and strategy on how to use and utilize the resources effectively as such it can achie...
发表评论
阅读全文